LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA
Clinical trials for LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to wipe out rare urinary tract cancer without surgery
Disease control Recruiting nowThis study tests a new drug called dabogratinib in 230 adults with a rare, low-grade cancer in the upper part of the urinary tract. The goal is to see if the drug can make the cancer disappear completely within 6 months. Participants take the drug by mouth and are monitored for s…
Matched conditions: LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jul 02, 2026 07:00 UTC
-
Gene therapy instilled into kidney shows promise for rare cancer
Disease control Recruiting nowThis early-phase trial is testing a gene therapy called nadofaragene firadenovec for people with low-grade upper tract urothelial cancer. The drug is instilled directly into the kidney's renal pelvis. The study aims to see if it is safe and can eliminate the cancer. Twenty adults…
Matched conditions: LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC